Case Study: Genmab accelerates screening analysis and improves data quality with IDBS ActivityBase XE

Genmab speeds screening results and improves data accuracy with IDBS

Genmab, a Danish biotech company, needed a flexible data management platform to capture, validate, and visualize screening data for its monoclonal antibody discovery programs. They turned to IDBS and implemented its ActivityBase XE solution to manage plate-based assays and help scientists perform trend analysis to find suitable disease targets.

IDBS's ActivityBase XE provided powerful visualization and curve-fitting capabilities, which sped up results generation and significantly improved data accuracy, quality, and workflow efficiency. The solution allowed all screening data to be stored in one accessible location, accelerating Genmab's research into therapeutics with great efficacy and tolerability.

Genmab